サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1159037

免疫腫瘍学市場：規模、シェア、動向、分析、予測（地域別、セグメント別、タイプ別、エンドユーザー別、2022年～2030年

Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User (Hospitals, Cancer Research Institute), 2022-2030
出版日: | 発行: GlobalData | ページ情報: 英文 109 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
免疫腫瘍学市場：規模、シェア、動向、分析、予測（地域別、セグメント別、タイプ別、エンドユーザー別、2022年～2030年
出版日: 2022年08月31日
発行: GlobalData
ページ情報: 英文 109 Pages
納期: 即納可能 即納可能とは
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の免疫腫瘍学の市場規模は、2021年に451億2,000万米ドルとなりました。同市場は、2022年～2030年にかけて20.30%のCAGRで拡大すると予測されています。

当レポートでは、免疫腫瘍学市場について調査し、市場の概要とともに、タイプ別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

目次

第1章 エグゼクティブサマリー

第2章 市場情勢

  • 市場概要
  • 調査範囲
  • 業界動向
  • 規制動向

第3章 バリューチェーン分析

  • 免疫腫瘍バリューチェーン

第4章 ポーターのファイブフォース分析

第5章 規制の枠組み

  • 米国の規制の枠組み
  • EUの規制の枠組み
  • 日本の規制の枠組み
  • 中国の規制の枠組み

第6章 免疫腫瘍学市場、主要8ヶ国のパイプライン分析

第7章 免疫腫瘍学市場、主要8ヶ国で上市された製品

第8章 市場規模：2022年～2030年

  • 主要医薬品の市場シェア分析
  • COVID-19の影響

第9章 世界の免疫腫瘍学市場、タイプ別

  • チェックポイントモジュレーター
  • 癌ワクチン
  • 細胞療法
  • 二重特異性抗体
  • サイトカイン
  • 腫瘍溶解性ウイルス

第10章 世界の免疫腫瘍学市場、エンドユーザー別

  • 病院
  • 癌研究センター
  • その他

第11章 世界の免疫腫瘍学市場、地域別

  • 北米
  • 欧州
  • アジア太平洋
  • その他の諸国

第12章 動向、促進要因、および課題

  • 市場動向
  • 市場促進要因分析
  • 市場の課題

第13章 会社

  • 競合分析
  • 会社プロファイリング - 現在の参入企業
  • Amgen Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche AG
  • Gilead Sciences Inc.
  • Johnson & Johnson Services Inc.
  • LEGEND BIOTECH CORP.
  • Merck & Co.
  • Novartis AG
  • Sanofi
  • その他の著名な将来の参入企業

第14章 付録

目次
Product Code: GDPH-SC-MR002

The immuno-oncology market size was valued at US$45.12 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 20.30% during 2022-2030. The immuno-oncology market report provides an executive-level overview of the immuno-oncology market worldwide today, with detailed forecasts of key indicators up to 2030.

This market intelligence report offers a thorough, forward-looking analysis of the global immuno-oncology market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.

The immuno-oncology market size was valued at US$45.12 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of is expected to grow at a CAGR of more than 19% during the forecast period (2022-2030). Major factors such as an increase in healthcare expenditure, a rise in the prevalence and incidence of cancer, a surge in technological advancement in cancer treatment, and novel product launches are expected to boost market growth during the forecast period.

Scope

  • Overview of immuno-oncology including classification of therapy and technologies, regulatory and market access details, and product & company profile
  • Immuno-oncology market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the class, end-users, and geographic segments.
  • Immuno-oncology market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the key class segments.
  • Immuno-oncology market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the end-user segment.
  • The competitive landscape: an examination of the positioning of leading players in the immune-oncology market.

Reasons to Buy

  • This market intelligence report offers a thorough, forward-looking analysis of the global immuno-oncology market and key opportunities in a concise format to help executives build proactive and profitable growth strategies.
  • Accompanying GlobalData's Forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in immuno-oncology markets.
  • The report also highlights key class and end-user segments.
  • With different charts and tables, the report is designed for an executive-level audience, boasting presentation quality.
  • The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from market players, which enables executives to quickly get up to speed with the current and emerging trends in immuno-oncology market.

Table of Contents

Table of Contents

Chapter 1. Executive Summary

  • 1.1 Global Immuno-oncology Market - Revenue Opportunity Snapshot
  • 1.2 Global Immuno-oncology Market: Key Segment Performance
  • 1.3 Key Findings

Chapter 2. Market Landscape

  • 2.1 Market Overview
    • 2.1.1 What is immuno-oncology?
    • 2.1.2 What is immuno-oncology according to regulators?
  • 2.2 Research Scope
  • 2.3 Industry trends
    • 2.3.1 Bispecific antibodies
    • 2.3.2 Cancer vaccines
    • 2.3.3 Cell Therapies
    • 2.3.4 Checkpoint Modulators
    • 2.3.5 Cytokines
    • 2.3.6 Oncolytic Viruses
  • 2.4 Regulatory Trends
    • 2.4.1 US
    • 2.4.2 EU
    • 2.4.3 Japan
    • 2.4.4 China

Chapter 3: Value Chain Analysis

  • 3.1 Immuno-oncology Value Chain
    • 3.1.1 Bispecific antibodies value chain overview
    • 3.1.2 Cancer vaccines value chain overview
    • 3.1.3 Cell therapies value chain overview
    • 3.1.4 Checkpoint modulators value chain overview
    • 3.1.5 Cytokines value chain overview
    • 3.1.6 Oncolytic viruses value chain overview

Chapter 4: Porter's Five Forces Analysis

  • 4.1 Global immuno-oncology market is competitive market characterized by high competition with differentiated products available

Chapter 5: Regulatory Framework

  • 5.2 US regulatory framework
    • 5.2.1 Key market access and regulatory concepts
  • 5.3 EU regulatory framework
    • 5.3.1 Key market access and regulatory concepts
  • 5.4 Japan regulatory framework
    • 5.4.1 Key market access and regulatory concepts
  • 5.5 China regulatory framework
    • 5.5.1 Key market access and regulatory concepts

Chapter 6: Immuno-oncology Market, Pipeline Analysis in 8MM

  • 6.3 Highest grossing pipeline products by class
    • 6.3.1 Bispecific antibody
    • 6.3.2 Vaccine products
    • 6.3.3 Cell therapy products
    • 6.3.4 Checkpoint modulator products
    • 6.3.5 Cytokine products
    • 6.3.6 Oncolytic virus products

Chapter 7: Immuno-Oncology Market, Marketed Products in 8 MM

Chapter 8: Market Size 2022-2030

  • 8.1 Market Share Analysis of Leading Drugs
  • 8.3 COVID-19 impact

Chapter 9: Global Immuno-oncology Market by Class

  • Checkpoint Modulators
  • Cancer Vaccines
  • Cell Therapies
  • Bispecific Antibodies
  • Cytokines
  • Oncolytic Viruses

Chapter 10: Global Immuno-oncology Market by End-User

  • Hospitals
  • Cancer Research Centers
  • Others

Chapter 11: Global Immuno-oncology Market by Geography

  • North America Immuno-oncology Market
  • Europe Immuno-oncology Market 2022-2030
  • Asia-Pacific Immuno-oncology Market 2022-2030
  • ROW Immuno-oncology market 2022-2030

Chapter 12: Trends, Drivers, and Challenges

    • 3.2.3 Market Trends
  • Technological advancement in immuno-oncology treatment
  • The emergence of combination therapies to treat different types of cancers
  • Increasing strategic partnerships and M&A
    • 3.2.1 Market Driver Analysis
  • Approval of novel therapies
  • Increase in financing and investments for immunotherapies
  • Increasing incidence and prevalence of cancer
    • 3.2.2 Market Challenges
  • High cost of immuno-oncology therapies
  • Challenges associated with identifying significant biomarkers for immunotherapies
  • Adverse effects of the immuno-oncology products

Chapter 13: Companies

  • Competitive analysis
  • Company profiling- Current players
  • Amgen Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche AG
  • Gilead Sciences Inc.
  • Johnson & Johnson Services Inc.
  • LEGEND BIOTECH CORP.
  • Merck & Co.
  • Novartis AG
  • Sanofi
  • Other prominent future players

Chapter 14: Appendix

  • 15.1 Sources
  • 15.2 Abbreviations
  • 15.3 Methodology
  • 15.4 Key Themes Impacting the Pharmaceutical Industry
  • Contact Us